Our Pricing

Best Weight Loss Injection at Lowest UK Prices

Published on: June 03, 2026

Finding the best weight loss injection UK lowest prices requires understanding which treatments deliver proven results at competitive costs. At Cured Pharmacy, we offer genuine UK-licensed weight loss injections including Mounjaro, Wegovy, and Saxenda with transparent upfront pricing, free clinical consultations under 3 minutes, and discreet delivery across the UK.

How Weight Loss Injections Work: GLP-1 and Dual-Agonist Mechanisms

The best weight loss injections available in the UK work by mimicking natural gut hormones that regulate appetite and blood sugar. GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda) activate a single pathway, whilst tirzepatide (Mounjaro) represents a breakthrough as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA [1].

These medications slow gastric emptying, reduce hunger signals to the brain, and improve insulin sensitivity. In clinical trials, patients typically report feeling fuller for longer periods, experiencing fewer food cravings, and achieving sustainable weight reduction when combined with lifestyle modifications [1][2].

The dual-agonist mechanism in Mounjaro activates both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously, producing greater metabolic effects than single-pathway treatments. This explains why tirzepatide consistently demonstrates superior weight loss outcomes in head-to-head comparisons [3].

Mounjaro (Tirzepatide): The Most Effective Weight Loss Injection UK

Mounjaro delivered the highest average weight reduction of any obesity medication in UK clinical trials. In the landmark SURMOUNT-1 trial, participants achieved up to 22.5% total body weight loss over 72 weeks on the 15mg maintenance dose — significantly exceeding results from semaglutide-based treatments [1].

At Cured Pharmacy, Mounjaro starts from £10 offering the best weight loss injection UK outcomes at competitive pricing. The treatment involves once-weekly subcutaneous injections using the pre-filled KwikPen device, with doses gradually escalated from 2.5mg to a maximum of 15mg based on individual tolerance and response [1].

Patients typically notice reduced appetite within the first week, with measurable weight loss becoming apparent after 4-8 weeks of consistent treatment. All Mounjaro prescriptions require clinical assessment by our UK-registered prescribers, who evaluate your medical history, current medications, and suitability for tirzepatide therapy.

Who Can Use Mounjaro for Weight Loss?

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your prescriber will assess whether you meet NICE criteria during your free online consultation.

The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Pregnant or breastfeeding women should not use Mounjaro, and adequate contraception is recommended for women of childbearing potential [1].

Wegovy (Semaglutide): Proven Weight Loss at Lower UK Prices

Wegovy contains semaglutide 2.4mg, the same active ingredient as Ozempic but specifically licensed for chronic weight management in the UK. In the STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks, establishing semaglutide as one of the most effective single-agonist treatments available [2].

Starting from £135.00 at Cured Pharmacy, Wegovy offers excellent value for patients seeking clinically proven weight loss injections. The once-weekly subcutaneous injection follows a dose-escalation schedule beginning at 0.25mg and increasing to the 2.4mg maintenance dose over 16 weeks, minimising gastrointestinal side effects during initiation [2].

Wegovy's established safety profile and extensive real-world use across the UK make it a trusted choice for weight management. Our UK prescribers frequently recommend semaglutide for patients who prefer a well-studied treatment with predictable outcomes and manageable side effects.

Wegovy vs Mounjaro: Clinical Comparison

Direct comparison studies suggest tirzepatide produces approximately 5-8% greater total body weight loss compared to semaglutide at therapeutic doses [3]. However, individual response varies considerably, and some patients achieve excellent results with semaglutide whilst experiencing tolerability issues with dual-agonist therapy.

Your UK prescriber will consider factors including your weight loss goals, medical history, previous treatment responses, and budget when recommending between Wegovy and Mounjaro. Both medications require commitment to dietary modifications and increased physical activity for optimal results.

Saxenda (Liraglutide): Daily Weight Loss Injection Option

Saxenda contains liraglutide 3mg, a GLP-1 receptor agonist administered as a daily subcutaneous injection. Unlike weekly treatments, Saxenda's daily dosing schedule provides more frequent appetite suppression, which some patients prefer for maintaining consistent control over food intake throughout the week [4].

Clinical trials demonstrated an average 8% body weight reduction over 56 weeks in participants using Saxenda alongside reduced-calorie diets and increased physical activity [4]. Whilst producing more modest weight loss compared to newer weekly injections, Saxenda remains a valuable option for patients who respond well to daily GLP-1 therapy.

Starting from £135.00 at Cured Pharmacy, Saxenda represents an accessible entry point for weight loss injection therapy. The treatment begins at 0.6mg daily and increases by 0.6mg increments each week until reaching the 3mg maintenance dose, allowing gradual adaptation to the medication's effects.

Alternative Weight Loss Treatments: Oral Medications

For patients who prefer not to use injections, several oral weight loss medications are available through Cured Pharmacy. Orlistat (Xenical, Alli, Orlos) works by blocking approximately 30% of dietary fat absorption in the intestines, resulting in average weight loss of 5-10% when combined with a reduced-calorie, lower-fat diet [5].

Orlistat requires three-times-daily dosing with meals and may cause gastrointestinal side effects including oily stools, flatulence, and faecal urgency, particularly when consuming high-fat foods. These effects often encourage adherence to lower-fat eating patterns, supporting long-term weight management behaviours [5].

Wegovy Oral Tablets represent a newer option, offering semaglutide in pill form for patients who cannot tolerate injections. Our UK prescribers can discuss whether injectable or oral treatments better suit your lifestyle, preferences, and clinical needs during your free consultation.

Choosing Between Injectable and Oral Weight Loss Treatments

Injectable GLP-1 medications consistently demonstrate superior weight loss outcomes compared to oral alternatives, with average reductions of 15-22% versus 5-10% respectively in clinical trials [1][2][5]. However, oral medications may be appropriate for patients with needle phobia, those seeking more modest weight reduction, or individuals with contraindications to GLP-1 therapy.

Your treatment choice should reflect your weight loss goals, medical suitability, tolerance for potential side effects, and practical considerations including dosing frequency and administration method. Our UK clinical team provides personalised recommendations based on comprehensive assessment of these factors.

Why Cured Pharmacy Offers the Best Weight Loss Injection UK Prices

As a fully registered UK online pharmacy (GPhC 9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), Cured Pharmacy guarantees the lowest prices on genuine UK-licensed weight loss medications. Unlike high-street pharmacies with significant overhead costs, our online model enables competitive pricing without compromising on clinical safety or medication quality.

We display transparent upfront pricing before your consultation, with no hidden fees or surprise charges. Every weight loss injection we dispense is sourced directly from UK-licensed wholesalers and stored in our temperature-controlled pharmacy facilities, ensuring you receive authentic medications in optimal condition.

Our free online consultation takes under 3 minutes to complete and is reviewed by UK-registered prescribers who specialise in weight management. If clinically appropriate, your prescription is processed the same day, with discreet packaging and tracked delivery options available across the UK. We also offer £10 off your first weight loss treatment, making it even more affordable to start your journey.

All prescription weight loss medications require clinical assessment to ensure safe, appropriate use. Our prescribers evaluate your BMI, medical history, current medications, and weight loss goals before approving treatment, providing the same rigorous clinical oversight you'd receive from your NHS GP whilst offering greater convenience and competitive pricing.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Jastreboff, A. M., Kaplan, L. M., Frías, J. P., et al. (2023). Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine, 389(6), 514–526. https://doi.org/10.1056/NEJMoa2301972 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment alongside dietary modifications and increased physical activity.